Members of the Carson Lab

CARSON LAB MEMBERS

Dionisia Quiroga, DO, PhD

Breast Medical Oncology Fellow; NIH T32 Post-Doctoral Research Fellow

Undergraduate Institution: Michigan State University
Medical School: Michigan State University
Graduate School: Michigan State University
Residency: Internal Medicine, The Ohio State University Wexner Medical Center
Fellowship: Medical Oncology, The Ohio State University Wexner Medical Center

Dionisia graduated from Michigan State University with her B.S. in physiology in 2007. She was then recruited to MSU’s Medical Scientist Training Program where she completed her medical and graduate school education. Her PhD research focused on the development of recombinant adenoviral vectors as cancer vaccine platforms under the direction of Dr. Andrea Amalfitano. Following completion of medical school, she matched into The Ohio State University’s ABIM Physician Scientist Research Pathway where she completed her internal medicine residency. Dionisia is currently a PGY-5 breast medical oncology fellow and NIH T32 research fellow in the Carson lab. Her clinical research focuses on the immunologic changes that occur in breast cancer-affected adipose tissue as well as the systemic inflammatory responses to breast cancer-associated lymphedema. Dionisia has been hired to start as a breast medical oncologist and assistant professor in the Division of Medical Oncology at OSU this August 2022 during which she will continue her research studies on breast cancer immunology and immunotherapy.

Debasish Sundi, MD

Assistant Professor, Urology, College of Medicine

Undergraduate Institution: Northwestern University
Medical School: Northwestern University, Feinberg School of Medicine
Residency: Urology, Johns Hopkins Medical Institutions
Fellowship: Urologic Oncology, University of Texas M.D. Anderson Cancer Center

Dr. Sundi is an expert urologic oncologist who studies bladder cancer. Dr. Sundi’s laboratory employs techniques in basic, translational, and clinical research to model the tumor immune microenvironment of bladder cancer and to optimize outcomes for patients. Dr. Sundi’s past research has been supported by the American Urological Association-Urology Care Foundation. Dr. Sundi’s current laboratory research support includes The Ohio State University Comprehensive Cancer Center, the Naren Patel Genitourinary Cancers Research Fund and grant funding from the U.S. Department of Defense. Active laboratory projects include studies of the bladder immune microenvironment during bladder carcinogenesis and basic/translational studies of sex-differences in bladder cancer immunity and response to immunotherapy. Research activities occur jointly in the Center for Translational Therapeutics and The Pelotonia Institute for Immuno-Oncology (PIIO).

Robert Wesolowski, MD

Associate Professor, Division of Medical Oncology

Undergraduate Institution: Hunter College
Medical School: SUNY Downstate Medical Center
Residency: Internal Medicine, Cleveland Clinic Foundation
Fellowship: Hematology and Oncology, Cleveland Clinic Foundation

Dr. Wesolowski joined the Division of Solid Tumor Oncology in 2010. His research interests include breast cancer immunology, in particular myeloid-derived suppressor cells (MDSC) and early phase trials of experimental therapeutics. MDSC are important inhibitors of anti-tumor immune response. He studying using MDSC as biomarkers of response to neoadjuvant chemotherapy and recently received a grant supporting this work. He also coordinates phase I solid tumor trials for the Division of Oncology, serves as local principal investigator on several phase I trials and is a member of the Precision Medicine Clinic where cancer patients will have their tumor DNA sequenced to identify cancers with gene mutations that have commercially available drugs that target these gene mutations. Dr. Wesolowski provides clinical care to women with all stages of invasive breast cancer and sees phase I patients in the Precision Medicine Clinic. Click here for his clinical website